T2 Biosystems Inc.

OTC: TTOO · Real-Time Price · USD
0.13
0.01 (8.79%)
At close: Apr 04, 2025, 3:42 PM

T2 Biosystems Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
2.08M 4.25M 6.21M 15.69M 24.32M 16.08M 10.12M 10.33M 20.37M 13.21M 9.4M 22.25M 22.05M 32.71M 10.69M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 9.99M 10M 20.04M 20.08M 22.62M
Long-Term Investments
n/a n/a 651K 651K 551K 551K n/a n/a 1.13M 1.13M 1.13M 1.55M 1.55M 551K 10M
Other Long-Term Assets
551K 552K -98K 4K 65K 49K 586K 1.69M 153K 156K 155K 153K 161K 78K 655K
Receivables
2.03M 1.3M 1.59M 1.42M 1.14M 1.35M 1.32M 2.16M 1.58M 2.72M 4.36M 5.13M 4.22M 3.98M 4.03M
Inventory
3.83M 5.17M 4.67M 4.82M 4.28M 4.34M 4.94M 4.29M 4.24M 5.67M 5.17M 3.91M 4.82M 4.78M 4.53M
Other Current Assets
1.84M 2.28M 3.09M 3.26M 3.14M 2.1M 2.55M 2.58M 2.69M 3.1M n/a n/a n/a n/a 2.72M
Total Current Assets
9.79M 13M 15.56M 25.09M 32.88M 23.87M 18.93M 19.36M 28.88M 24.7M 33.5M 44.39M 54.46M 63.86M 44.59M
Property-Plant & Equipment
7.75M 8.17M 8.64M 9.05M 9.79M 12.66M 13.22M 13.27M 13.79M 13.62M 14.25M 14.44M 13.87M 14.41M 14.81M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
8.3M 8.72M 9.19M 9.71M 10.4M 13.26M 13.81M 14.97M 15.08M 14.9M 15.54M 16.14M 15.58M 15.04M 25.46M
Total Assets
18.08M 21.72M 24.75M 34.8M 43.28M 37.13M 32.73M 34.33M 43.95M 39.6M 49.04M 60.54M 70.04M 78.9M 70.05M
Account Payables
4.21M 1.69M 1.89M 1.53M 1.09M 2.23M 3.13M 1.3M 2.06M 5.23M 3.38M 2.83M 2.62M 2.89M 3.91M
Deferred Revenue
233K 237K 185K 224K 276K 265K 149K 172K 163K 142K 338K 518K 613K 438K 400K
Short-Term Debt
13.65M 13.47M 43.32M 42.9M 42.45M 52.05M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
1.21M 2.12M 7.46M 7.18M 6.86M 7.25M 7.97M 39K 3.53M n/a n/a n/a n/a n/a n/a
Total Current Liabilities
24.43M 21.8M 56.26M 56.15M 55.45M 66.06M 17.83M 10.13M 10.94M 13.19M 12.67M 11.69M 11.4M 9.35M 10.4M
Long-Term Debt
n/a n/a n/a n/a n/a n/a 50.11M 49.65M 49.19M 48.71M 48.26M 47.79M 47.13M 46.49M 45.85M
Other Long-Term Liabilities
59K n/a n/a n/a n/a n/a 6.78M 5.94M 6.91M 6.38M 4.65M 4.58M 4.25M 3.95M 3.83M
Total Long-Term Liabilities
5.36M 5.82M 6.27M 6.68M 7.06M 7.5M 64.79M 63.85M 64.68M 63.93M 62.02M 61.75M 61.1M 60.54M 60.22M
Total Liabilities
29.79M 27.62M 62.53M 62.83M 62.52M 73.55M 82.62M 73.98M 75.62M 77.12M 74.69M 73.44M 72.5M 69.89M 70.62M
Total Debt
18.94M 19.22M 49.5M 49.5M 49.48M 59.48M 59.35M 59.22M 59.05M 58.68M 58.51M 57.15M 57.97M 57.62M 56.11M
Book Value
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Book Value Per Share
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock
18K 17K 6K 4K 4K 242K 21K n/a 7K 198K 171K 166K 166K 165K 148K
Retained Earnings
-616.91M -606.79M -597.83M -584.3M -573.96M -558.53M -552.18M -534.22M -524.12M -506.75M -488.71M -472.22M -460.07M -446.11M -433.63M
Comprehensive Income
n/a n/a n/a 0.00 n/a n/a n/a n/a n/a n/a -11K -4K 4K 4K 16K
Shareholders Equity
-11.71M -5.9M -37.77M -28.04M -19.24M -36.42M -49.89M -39.66M -31.67M -37.52M -25.65M -12.9M -2.46M 9.01M -566K
Total Investments
n/a 651K 651K 651K 551K 551K n/a n/a 1.13M 1.13M 9.99M 10M 20.04M 20.08M 32.62M